Immune profiling leads to implications for immunotherapy for NF1-associated tumors – Medical Xpress
|
Immune profiling leads to implications for immunotherapy for NF1-associated tumors
Medical Xpress Neurofibromatosis type 1 (NF1)—an autosomal dominant disorder affecting approximately one in every 3,500 people—results in dysfunctional neurofibromin, a protein expressed throughout the body and involved in the RAS signaling pathway. Virtually all … |
